Trial Profile
A retrospective study assessing long-term persistence of bisphosphonates versus denosumab in women with osteoporosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Apr 2018
Price :
$35
*
At a glance
- Drugs Denosumab (Primary) ; Alendronic acid; Bisphosphonates; Bisphosphonates; Ibandronic acid; Risedronic acid; Zoledronic acid
- Indications Osteoporosis
- Focus Adverse reactions
- Acronyms GRAND-4
- 27 Apr 2018 New trial record